Table 1 Clinical and sociodemographic features of the sample
n | % | ||
|---|---|---|---|
Number of participants | 41 | ||
Gender | |||
Male | 31 | 75.6 | |
Female | 10 | 24.4 | |
Duration of use | |||
<5 years | 14 | 34.1 | |
5-9 years | 12 | 29.3 | |
>10 years | 14 | 34.1 | |
Could not recall | 1 | 2.4 | |
Age of onset | |||
<25 | 15 | 36.6 | |
25-39 | 18 | 43.9 | |
>40 | 7 | 17.1 | |
Could not recall | 1 | 2.4 | |
Employment status | |||
Employed | 12 | 29.3 | |
Not employed | 11 | 26.8 | |
Retired | 1 | 2.4 | |
Disability pension | 16 | 39.0 | |
No data | 1 | 2.4 | |
Diazepam equivalent dosages | |||
<50 mg | 14 | 34.1 | |
50-99 mg | 14 | 34.1 | |
>100 mg | 13 | 31.7 | |
Lifetime substance use except for benzodiazepines | |||
None | 4 | 9.8 | |
One | 8 | 19.5 | |
More than one | 29 | 70.7 | |
Number of comorbid psychiatric diagnosis groups except substance use disorders (F2, F3, F4, F6, F9) | |||
None | 10 | 24.4 | |
One | 15 | 36.6 | |
More than one | 16 | 39.0 | |
Comorbid psychiatric diagnosis groups except substanc use disorders | |||
F2 | 1 | 2.4 | |
F3 | 21 | 51.2 | |
F4 | 12 | 29.3 | |
F6 | 14 | 34.1 | |
F9 | 1 | 2.4 |